We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$32.1M |
| 2 |
Intel
INTC
|
+$28.7M |
| 3 |
Gilead Sciences
GILD
|
+$27.7M |
| 4 |
APA Corp
APA
|
+$27.5M |
| 5 |
Costco
COST
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OPTU
Optimum Communications Inc
OPTU
|
+$41M |
| 2 |
Align Technology
ALGN
|
+$38.9M |
| 3 |
Qualcomm
QCOM
|
+$33.6M |
| 4 |
H&R Block
HRB
|
+$31.8M |
| 5 |
CBRE Group
CBRE
|
+$28.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Healthcare | 14.08% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 13.05% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
401
Centerspace
CSR
$952M
| $4.96M | 0.04% |
70,181
-2,421
| -3% | -$170K |
|
402
Avient
AVNT
$3.29B
| $4.94M | 0.04% |
122,568
-3,504
| -3% | -$124K |
|
|
ODT
403
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $4.9M | 0.04% |
255,202
+178,169
| +231% | +$2.75M |
|
404
Editas Medicine
EDIT
$399M
| $4.86M | 0.04% |
69,345
-20,675
| -23% | -$849K |
|
|
DBD
405
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.83M | 0.04% |
452,835
-22,469
| -5% | -$204K |
|
406
AT&T
T
$164B
| $4.8M | 0.04% |
221,103
+7,060
| +3% | +$152K |
|
407
Axcelis
ACLS
$3.44B
| $4.74M | 0.04% |
162,657
-4,917
| -3% | -$127K |
|
408
Jack in the Box
JACK
$314M
| $4.72M | 0.04% |
50,849
-13,611
| -21% | -$1.19M |
|
409
Accuray
ARAY
$27.5M
| $4.66M | 0.04% |
1,116,320
-35,549
| -3% | -$130K |
|
|
APLS
410
DELISTED
Apellis Pharmaceuticals
APLS
| $4.6M | 0.04% |
80,381
-39,862
| -33% | -$1.69M |
|
|
KYNB
411
Kyntra Bio
KYNB
$27.4M
| $4.54M | 0.04% |
4,892
-2,833
| -37% | -$2.98M |
|
412
Andersons Inc
ANDE
$2.39B
| $4.52M | 0.04% |
184,451
+117,823
| +177% | +$2.62M |
|
413
Scholastic
SCHL
$774M
| $4.5M | 0.04% |
180,200
-1,050
| -0.6% | -$24.1K |
|
414
Corpay
CPAY
$25.7B
| $4.48M | 0.04% |
16,435
-1,369
| -8% | -$351K |
|
|
415
H&R Block
HRB
$5.98B
| $4.46M | 0.04% |
280,878
-1,841,619
| -87% | -$31.8M |
|
416
Allegiant Air
ALGT
$2.57B
| $4.42M | 0.04% |
23,380
+53
| +0.2% | +$8.13K |
|
417
Inspire Medical Systems
INSP
$1.47B
| $4.4M | 0.04% |
23,392
-2,000
| -8% | -$327K |
|
418
Universal Insurance Holdings
UVE
$1.26B
| $4.38M | 0.04% |
289,632
-1,387
| -0.5% | -$19.6K |
|
|
CIVI
419
DELISTED
Civitas Resources
CIVI
| $4.37M | 0.04% |
226,019
-15,010
| -6% | -$315K |
|
|
SRDX
420
DELISTED
Surmodics
SRDX
| $4.36M | 0.04% |
100,197
-26,914
| -21% | -$1.06M |
|
421
Acco Brands
ACCO
$399M
| $4.36M | 0.04% |
+515,894
| New | +$3.75M |
|
422
OneSpan
OSPN
$584M
| $4.35M | 0.04% |
+210,530
| New | +$4.52M |
|
423
Coherus Oncology
CHRS
$217M
| $4.35M | 0.04% |
250,134
+100,489
| +67% | +$1.79M |
|
424
Hilltop Holdings
HTH
$2.26B
| $4.31M | 0.04% |
156,626
-6,074
| -4% | -$146K |
|
425
Tyson Foods
TSN
$21.5B
| $4.25M | 0.04% |
+65,912
| New | +$4.1M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2020 Portfolio in Review
As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
- Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
- Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
- Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
- Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.